CEO, Dr. Yousef presented Juvena’s approach to mining the regenerative secretomes of human pluripotent stem cells to identify and develop novel disease-modifying biologics that promote tissue regeneration and repair in order to rejuvenate lives as the 14th annual drug discovery strategic summit this year.
Congratulations to Juvena Therapeutics Co-Founder and CEO Dr. Yousef for being named a “Big Think” speaker at #BioFuture2023 in recognition of the company’s accelerated growth and momentum in addressing a long-standing critical gap in drug discovery by unlocking the therapeutic potential of secreted proteins in order to develop regenerative therapeutics.
Our Director of Discovery and Platform, Dr. Thach Mai and CSO Dr. Jeremy O’Connell share more about Juvena’s discovery platform and approach to identifying and developing a regenerative biologics for promoting lung epithelium re-growth for the treatment of idiopathic pulmonary fibrosis at the IPF 2023 Annual summit.
Juvena is delighted to have had the opportunity to participate in the Mubadala Capital Singapore Forum. CEO Dr. Yousef was on the panel, “The New Frontier of Biotech Investing & Company Creation”
Juvena’s CSO, Dr. Jeremy O’Connell, and VP Dr. Mo Tabrizi attend and present our DM1 lead program at the annual Myotonic Dystrophy Foundation Conference which we are proud to sponsor
Excited to announce Juvena’s CEO, Dr. Yousef’s participation at the Longevity Summit: Ending Age-Related Diseases in NYC on August 10-11! Join her and other experts as we revolutionize the field of aging research. Learn more and register here
Wu Xi Apptec spotlights Juvena Therapeutics on their Spotlight III: “The Next Wave of Rare Disease Therapeutics” episode. Our CEO, Dr. Yousef discusses Juvena’s unique approach to developing innovative disease-modifying biologics for chronic and rare degenerative diseases by mapping the therapeutic potential of secreted proteins. Learn more and register for the July 27 episode here.
Juvena’a CEO, Dr. Hanadie Yousef discusses “Harnessing the Regenerative Secretome of Human Pluripotent Stem Cells” with other industry leaders discussing key areas of innovation advancing human healthspan and longevity at the Second Annual Longevity Summit
Juvena’s lead drug discovery Scientist, Dr. Thach Mai, gave an excellent lecture, “Mapping Secreted Proteins to Unmet Medical Needs” to graduate students at Maastricht Centre for Systems Biology (MaCSBio). Dr. Mai outlined Juvena’s use of machine learning and computational tools to unravel the therapeutic potential of stem cell-secreted human proteins
